Advertisement

Exposure Assessment Methods for Veterinary and Human-Use Medicines in the Environment: PEC vs. MEC Comparisons

  • C.D. Metcalfe
  • A.C. Alder
  • B. Halling-Sørensen
  • K. Krogh
  • K. Fenner
  • M. Larsbo
  • J. O. Straub
  • T. A. Ternes
  • E. Topp
  • D. R. Lapen
  • A. B. A. Boxall

Keywords

European Union Sewage Sludge Environmental Risk Assessment Environ Toxicol Veterinary Antibiotic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aga DS, Goldfish R, Kulshrestha P (2003) Application of ELISA in determining the fate of tetracyclines in land-applied livestock wastes. Analyst 128:658–662CrossRefGoogle Scholar
  2. Al-Ahmad A, Daschner FD, Kümmerer K (1999) Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of wastewater bacteria. Arch Environ Contam Toxicol 37:158–167CrossRefGoogle Scholar
  3. Alder AC, Bruchet A, Carballa M, Clara M, Joss A, Löffler D (2006) Consumption and occurrence. In: Ternes TA, Joss A (eds) Human pharmaceuticals, hormones and fragrances: the challenge of micropollutants in urban water management. IWA Publishing, London, UKGoogle Scholar
  4. Alder AC, Schaffner C, Majewsky M, Klasmeier J, Fenner K (in preparation) Predictability of surface water concentrations of human pharmaceuticals. Measured and predicted concentrations of betablockers in the Glatt valley watershed, Switzerland.Google Scholar
  5. Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333:167–184CrossRefGoogle Scholar
  6. Beven K, Binley A (1992) The future of distributed models: model calibration and uncertainty prediction. Hydrol Process 6:279–298CrossRefGoogle Scholar
  7. Bourne GR (1981) The metabolism of â-adrenoreceptor blocking drugs. In: Bridges JW, Chasseaud LF (eds) Progress in drug metabolism, vol 6. Wiley, London, UKGoogle Scholar
  8. BLAC (2003) Arzneimittel in der Umwelt – Auswertung der Untersuchungsergebnisse: Hamburg: Freie und Hansestadt Hamburg, Behörde für Umwelt und Gesundheit, Umweltuntersuchungen im Auftrag des Bund/Länderausschuss für Chemikaliensicherheit (BLAC), Hamburg GermanyGoogle Scholar
  9. Boxall ABA, Blackwell PA, Cavallo R, Kay P, Tolls J (2005) The sorption and transport of a sulphonamide antibiotic in soil systems. In: Dietrich D (ed) Hot spot pollutants: pharmaceuticals in the environment. Elsevier, The NetherlandsGoogle Scholar
  10. Boxall ABA, Fogg L, Baird D, Telfer T, Lewis C, Gravell A, Boucard T (2006) Targeted monitoring study for veterinary medicines. UK Environment Agency, Bristol, UK (Environment Agency R&D Technical Report)Google Scholar
  11. Burkhard M, Stamm S, Waul C, Singer H, Muller S (2005) Surface runoff and transport of sulfonamide antibiotics on manured grassland. J Environ Qual 34:1363–1371CrossRefGoogle Scholar
  12. Cannavan A, Coyne R, Kennedy DG, Smith P (2000) Concentration of 22,23-dihydroavermectin B sub(1a) detected in the sediments at an Atlantic salmon farm using orally administered ivermectin to control sea-lice infestation. Aquaculture 182:229–240CrossRefGoogle Scholar
  13. Carsel RF, Smith CN, Mulkey LA, Dean JD, Jowise P (1984). User’s manual for the pesticide root zone model (PRZM): Release 1. EPA-600/3-84-109. U.S. Environmental Protection Agency, Athens, GA, USAGoogle Scholar
  14. CHMP (2006) Guideline on the environmental risk assessment of medicinal products for human use. Committee for Human Use Medicinal Products, European Medicines Agency (EMEA), London, UK (www.emea.europa.eu/pdfs/human/swp/444700en.pdf)Google Scholar
  15. Cunningham VL, Constable DJC, Hannah RE (2004) Environmental risk assessment of paroxetine. Environ Sci Technol 38:3351–3359CrossRefGoogle Scholar
  16. CVMP (2006) Guideline on environmental impact assessment for veterinary medicinal products, in support of the VICH guidelines GL6 and GL38, Committee for Veterinary Medicine Products, European Medicines Agency (EMEA), London, UK (www.emea.europa.eu/pdfs/vet/era/EPAworkprogramme.pdf)Google Scholar
  17. Ericson JF (2007) An evaluation of the OECD 308 water/sediment systems for investigating the biodegradation of pharmaceuticals. Environ Sci Technol 41:5803–5811CrossRefGoogle Scholar
  18. European Commission (2001) Organic contaminants in sewage sludge for agricultural use, Report coordinated by the European Commission Joint Research Centre, Institute for Environment and Sustainability, Soil and Waste Unit, Germany (http://ec.europa.eu/environment/waste/sludge/pdf/organics- in-sludge.pdf)Google Scholar
  19. European Commission (2003) Technical guidance document on risk assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified substances, Commission Regulation (EC) No 1488/94 on risk assessment for existing substances, Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (http:// jrc.ecb.eu.it/)Google Scholar
  20. FOCUS (2000) FOCUS groundwater scenarios in the EU review of active substances – The report of the work of the Groundwater Scenarios Workgroup of FOCUS (Forum for the Co-ordination of pesticide fate models and their Use), Version 1 of November 2000. EC Document Reference Sanco/321/ 2000, revision 2Google Scholar
  21. Frishman WH, Alwarshetty M (2002) Beta-adrenergic blockers in systemic hypertension – Pharmacokinetic considerations related to the current guidelines. Clinical Pharmacokinetics 41:505–516CrossRefGoogle Scholar
  22. Gobel A, Thomsen A, McArdell CS, Alder AC, Giger W, Theiss N, Löffler D, Ternes TA (2005) Extraction and determination of sulfonamides, macrolides, and trimethoprim in sewage sludge. J Chromatog A 1085:179–189CrossRefGoogle Scholar
  23. Golet EM, Strehler A, Alder AC, Giger W (2002) Determination if fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction. Anal Chem 74:5455–5462CrossRefGoogle Scholar
  24. Gujer W (1990) Seidlungswasserwirtschaft. Springer-Verlag, Berlin, GermanyGoogle Scholar
  25. Hales SG, Feijtel T, King H, Fox K, Verstraete W (1997) Biodegradation kinetics: Generation and use of data for regulatory decision making. SETAC-Europe Workshop, Sept. 4-6, 1996, Port-Sunlight, UKGoogle Scholar
  26. Halling-Sørensen B, Jacobsen A-M, Jensen J, Sengelov G, Vaclavik E, Ingerslev F (2005) Dissipation and effects of chlortetracycline and tylosin in two agricultural soils: a field-scale study in Southern Denmark. Environ Toxicol Chem 24:802–810CrossRefGoogle Scholar
  27. Herd RP, Sams RA, Ashcraft SM (1996) Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on formulation. Int J Parasit 26:1087–1093CrossRefGoogle Scholar
  28. Jarvis NJ, Stähli M, Bergström L, Johnsson H (1994) Simulation of dichlorprop and bentazon leaching in soils of contrasting texture using the MACRO model. J Environ Sci Health A29:1255–1277CrossRefGoogle Scholar
  29. Jensen J, Jepsen S-E (2005) The production, use and quality of sewage sludge in Denmark. Waste Management 25:239–247CrossRefGoogle Scholar
  30. Jones OAH, Voulvoulis N, Lester JN (2005) Human pharmaceuticals in wastewater treatment processes. Crit Rev Environ Sci Technol 35:401-427CrossRefGoogle Scholar
  31. Joss A, Andersen H, Ternes TA, Richle PR, Siegrist H (2004) Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: Consequences for plant optimization$. $Environ Sci Technol 38:3047–3055CrossRefGoogle Scholar
  32. Joss A, Zabczynski S, Gobel A, Hoffmann B, Löffler D, McArdell CS, Ternes TA, Thomsen A, Siegrist H (2006a) Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme. Water Res 40:1686–1696CrossRefGoogle Scholar
  33. Joss A, Carballa M, Kreuzinger N, Siegrist H, Zabczynski A (2006b) Wastewater treatment. In: Ternes TA, Joss A (eds) Human pharmaceuticals, hormones and fragrances: the challenge of micropollutants in urban water management. IWA Publishing, London, UKGoogle Scholar
  34. Kay P, Blackwell P, Boxall ABA (2004) Fate and transport of veterinary antibiotics in drained clay soils. Environ Toxicol Chem 23:1136–1144CrossRefGoogle Scholar
  35. Kinney CA, Furlong ET, Zaugg SD, Burkhardt MR, Werner SL, Cahill JD, Jorgensen GB (2006) Survey of organic wastewater contaminants in biosolids destined for land application. Environ Sci Technol 40:7207–7215CrossRefGoogle Scholar
  36. Klein M (1995) PELMO: Pesticide Leaching Model, User manual version 2.01. Fraunhofer-Institut für Umweltchemie und ökotoxikogie, GermanyGoogle Scholar
  37. Kolpin DW, Skopec M, Meyer MT, Furlong ET, Zaugg SD (2004) Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci Total Environ 328:119–130CrossRefGoogle Scholar
  38. Kuhlmann J, Dalhoff A, Zeiler HJ (1998) Quinolone antibacterials. In: Handbook of experimental pharmacology. Springer-Verlag, Berlin, GermanyGoogle Scholar
  39. Lapen DR, Topp E, Metcalfe CD, Li H, Edwards M, Gottschall N, Bolton P, Curnoe W, Payne M, Beck A (in press) Pharmaceuticals and personal care products in tile drainage following land application of municipal biosolids. Sci Total EnvironGoogle Scholar
  40. Larsbo M, Jarvis N (2003) MACRO 5.0. A model of water flow and solute transport in macroporous soil, technical description. Emergo 6, Swedish University of Agricultural Science, Dept. Soil Science, Uppsala, SwedenGoogle Scholar
  41. Larsbo M, Lapen DR, Topp E, Metcalfe CD, Abbaspour K, Fenner K (in preparation) Simulation of pharmaceutical and personal care transport to tile drains.Google Scholar
  42. Lienert J, Güdel K, Escher BI (2007) Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes\textbf. Environ Sci Technol 41:4471–4476CrossRefGoogle Scholar
  43. Mackay N, Mason P, Di Guardo A (2005) VetCalc exposure modelling tool for veterinary medicines: user manual. Report to the Veterinary Medicines Directorate, Addlestone, UKGoogle Scholar
  44. Maurer M, Escher BI, Richle P, Schaffner C, Alder AC (2007) Elimination of β-blockers in sewage treatment plants. Water Res 41:1614–1622CrossRefGoogle Scholar
  45. Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA, Hirsch R (2003) Occurrence of acidic and neutral drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22:2872–2880CrossRefGoogle Scholar
  46. Metcalfe CD, Boxall A, Fenner K, Kolpin D, Servos M, Silberhorn E, Staveley J (in press) Exposure assessment of veterinary medicines in aquatic systems, In: Crane M, Barrett K, Boxall ABA (eds) Veterinary medicines in the environment. SETAC Press, Pensacola, FL, USAGoogle Scholar
  47. Miao X-S, Yang J-J, Metcalfe CD (2005) Fate of carbamazepine and its metabolites in a municipal wastewater treatment plant. Environ Sci Technol 39:7469–7475CrossRefGoogle Scholar
  48. Perez S, Eichhorn P, Aga DS (2005) Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment. Environ Toxicol Chem 24:1361–1367CrossRefGoogle Scholar
  49. Robinson PF, Liu QT, Riddle AM, Murray-Smith R (2007) Modeling the impact of direct phototransformation on predicted environmental concentrations (PECs) of propranolol hydrochloride in UK and US rivers. Chemosphere 66:757–766Google Scholar
  50. Spaepen KRI, Leemput LJJ, Wislocki PG, Verschueren C (1997) A uniform procedure to estimate the predicted environmental concentration of the residues of veterinary medicines in soil. Environ Toxicol Chem 16:1977–1982Google Scholar
  51. Stoob K, Singer HP, Mueller SR, Schwarzenbach RP, Stamm CH (2007) Dissipation and transport of veterinary sulphonamide antibiotics after manure application to grassland in a small catchment. Environ Sci Technol 41:7349–7355CrossRefGoogle Scholar
  52. Straub JO (2006) Matters of fact and of fiction: European PECs and MECs of ibuprofen. Poster, SETAC Europe 16th Annual Meeting, May 7–11, 2006, The Hague, the NetherlandsGoogle Scholar
  53. Straub JO (this volume) Deterministic and probabilistic environmental risk assessment for diazepam. In: Kümmerer K (ed) Pharmaceuticals in the environment, 3rd edn. Springer-Verlag, Berlin, GermanyGoogle Scholar
  54. Straub JO, Stewart KM (2007) Deterministic and probabilistic acute-based environmental risk assessment for naproxen for western Europe. Environ Toxicol Chem 26: 795–806CrossRefGoogle Scholar
  55. Ternes TA (2000) Residues of pharmaceuticals, diagnostics and antiseptics in wastewater, rivers and groundwater – a new challenge for the water technology. (Rückstände an Arzneimitteln, Diagnostika und Antiseptika in Abwasser, Flüssen und Grundwasser – eine neue Herausforderung für die Wasserwirtschaft), Gutenberg-University Mainz, GermanyGoogle Scholar
  56. Ternes TA, Herrmann N, Bonerz M, Knacker T, Siegrist H, Joss A (2004) A rapid method to measure the solid-water distribution coefficient ($K$d) for pharmaceuticals and musk fragrances in sewage sludge. Water Res 38:4075-4084CrossRefGoogle Scholar
  57. Tolls J (2001) Sorption of veterinary medicines: a review. Environ Sci Technol 35:3397–3406CrossRefGoogle Scholar
  58. Topp E, Monteiro SC, Beck A, Ball Coelho B, Boxall ABA, Duenk PW, Kleywegt S, Lapen DR, Payne M, Sabourin L, Li H, Metcalfe CD (2008) Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Sci Total Environ 396:52–59Google Scholar
  59. Versteeg DJ, Alder AC, Cunningham VL, Kolpin DW, Murray-Smith R, Ternes T (2005) Environmental exposure modelling and monitoring of human pharmaceutical concentrations in the environment. In:Human Pharmaceuticals: Assessing the Impacts on Aquatic Ecosystems. SETAC Press, Pensacola, FL, USAGoogle Scholar
  60. VICH (2004) Environmental impact assessment (EIAs) for veterinary medicinal products (VMPs) – Phase II, Draft Guidance, August, 2003, International Cooperation on Harmonization of the Technical Requirements for Registration of Veterinary Medicinal Products (available at: http:// vich.eudra.org/pdf/10_2003/g138_st4.pdf)Google Scholar
  61. Water UK (2006) Recycling of biosolids to land. Water UK, London, UK (http://www.water.org.uk/home/ news/press-releases/biosolids-and-agriculture-/final-revisedbiosolids-briefing-pack-2006-v8.pdf)Google Scholar
  62. Xia K, Bhandari A, Das K, Greg P (2005) Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosoilds. J Environ Qual 34:91–104CrossRefGoogle Scholar
  63. Zwiener C, Frimmel FH (2003) Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci Total Environ 309:201–211CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • C.D. Metcalfe
    • 1
  • A.C. Alder
    • 2
  • B. Halling-Sørensen
    • 3
  • K. Krogh
    • 3
  • K. Fenner
    • 2
  • M. Larsbo
    • 4
  • J. O. Straub
    • 5
  • T. A. Ternes
    • 6
  • E. Topp
    • 7
  • D. R. Lapen
    • 7
  • A. B. A. Boxall
    • 8
  1. 1.Environmental and Resource StudiesTrent University OntarioCanad
  2. 2.Swiss Federal Institute of Aquatic Science and Technoloy (Eawag)Switzerland
  3. 3.Copenhagen UniversityDenmark
  4. 4.Swedish University of Agricultural ScienesSweden
  5. 5.Corporate Safety, Health & Environmental ProtectionSwitzerland
  6. 6.Bundesanstalt für Gewässerkunde (BfG)Germany
  7. 7.Agriculture and Agri-Food CanadaCanada
  8. 8.Central Sciences Laboratory Sand HuttonUnited Kingdom

Personalised recommendations